Literature DB >> 11198215

Combined endovascular therapy of ruptured aneurysms and cerebral vasospasm.

I Wanke1, A Dörfler, U Dietrich, T Aalders, M Forsting.   

Abstract

We describe two patients with subarachnoid haemorrhage due to a ruptured intracranial aneurysm and severe symptomatic vasospasm. The aneurysm was occluded with detachable coils followed by intra-arterial infusion of papaverine to treat vasospasm as an one-stage procedure. There was significant resolution of the vasospasm. The long-term clinical outcome in one patient was excellent, the other still has minor deficits. Combined endovascular aneurysm therapy followed by intra-arterial spasmolysis with papaverine is a technically feasible therapeutic alternative in patients with symptomatic vasospasm.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11198215     DOI: 10.1007/s002340000479

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  4 in total

1.  Endovascular surgery for ruptured aneurysms with vasospasm.

Authors:  A Kurata; S Suzuki; J Niki; H Ozawa; M Yamada; K Fujii; S Kan; T Kitahara; Y Miyasaka; T Ohmomo
Journal:  Interv Neuroradiol       Date:  2007-06-27       Impact factor: 1.610

2.  Intradural Aneurysm Caused by Arterial Injury during Surgery: Treatment with Coil Embolization.

Authors:  I Oran; M Parildar; T Dalbasti; A Memis; N Ozdamar
Journal:  Interv Neuroradiol       Date:  2002-01-10       Impact factor: 1.610

3.  Continuous intra-arterial infusion of nimodipine during embolization of cerebral aneurysms associated with vasospasm.

Authors:  I Oran; C Cinar
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-07       Impact factor: 3.825

4.  Endovascular treatment of middle cerebral artery aneurysms with electrolytically detachable coils.

Authors:  A Doerfler; I Wanke; S L Goericke; H Wiedemayer; T Engelhorn; E R Gizewski; D Stolke; M Forsting
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.